Diagnostic testing and laboratory equity in clinical microbiology
- PMID: 38916359
- PMCID: PMC11302658
- DOI: 10.1128/spectrum.01222-24
Diagnostic testing and laboratory equity in clinical microbiology
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- CDC . 2022. What is health equity? Available from: https://www.cdc.gov/healthequity/whatis/index.html
-
- Boyd K, Kouamou V, Hlupeni A, Tangwena Z, Ndhlovu CE, Makadzange AT, Crypto A. 2022. Diagnostic accuracy of point of care cryptococcal antigen lateral flow assay in fingerprick whole blood and urine samples for the detection of asymptomatic cryptococcal disease in patients with advanced HIV disease. Microbiol Spectr 10:e0107522. doi:10.1128/spectrum.01075-22 - DOI - PMC - PubMed
-
- Troyano-Hernáez P, Herrador P, Gea F, Romero-Hernández B, Reina G, Albillos A, Galán JC, Holguín Á. 2023. Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection. Microbiol Spectr 11:e0174823. doi:10.1128/spectrum.01748-23 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical